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Abstract
Background: Several different cDNA labeling methods have been developed for microarray based
gene expression analysis. We have examined the accuracy and reproducibility of such five
commercially available methods in detection of predetermined ratio values from target spike
mRNAs (A. thaliana) in a background of total RNA. The five different labeling methods were: direct
labeling (CyScribe),  indirect labeling  (FairPlay™ – aminoallyl), two protocols with dendrimer
technology (3DNA® Array 50™ and 3DNA® submicro™), and hapten-antibody enzymatic labeling
(Micromax™ TSA™). Ten spike controls were mixed to give expected Cy5/Cy3 ratios in the range
0.125 to 6.0. The amounts of total RNA used in the labeling reactions ranged from 5 – 50 µg.
Results: The 3DNA array 50 and CyScribe labeling methods performed best with respect to
relative deviation from the expected values (16% and 17% respectively). These two methods also
displayed the best overall accuracy and reproducibility. The FairPlay method had the lowest total
experimental variation (22%), but the estimated values were consistently higher than the expected
values (36%). TSA had both the largest experimental variation and the largest deviation from the
expected values (45% and 48% respectively).
Conclusion: We demonstrate the usefulness of spike controls in validation and comparison of
cDNA labeling methods for microarray experiments.
Background
High-throughput global gene expression analysis with
cDNA- and oligonucleotide-based microarrays has
become a common research tool [1,2]. Unfortunately, the
method still suffers from inadequate precision due to the
many sources of variation during the experimental proc-
ess [3-5]. Some important parameters to ensure a reliable
cDNA microarray experiment are: 1) the quality of the
glass-slide, 2) the quality and quantity of the probes (e.g.
PCR-products) printed on the glass-slide, 3) the quality
and quantity of the RNA samples, 4) the cDNA labeling
method, 5) the hybridization protocol, and 6) the scan-
ning procedure. Many efforts have been made to optimize
and standardize each of these steps [6-16], but there are
still a limited number of data sets describing all methods
and strategies in use, especially regarding the labeling of
cDNA target samples. Recently the reproducibility, sensi-
tivity and accuracy of a selection of different labeling
methods in cDNA microarray hybridization have been
compared [13-16]. However, none of these studies have
used external mRNA standards (spikes) with
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predetermined ratio distribution in evaluation of accuracy
and reproducibility of the different methods.
In this study, we have added various amounts of 10 differ-
ent spike mRNAs (Arabidopsis thaliana) in two samples
of total RNA. The ratio data generated from these spikes
were used to evaluate and compare five different commer-
cially available cDNA labeling methods.
Results and discussions
We have used an approach based on a series of external
standards (spikes) to evaluate the reproducibility and
accuracy of five commercially available cDNA labeling
methods: direct labeling (CyScribe), indirect labeling
(FairPlay), two protocols with dendrimer technology:
3DNA Array 50 (3DNA50) and 3DNA submicro (3DNA),
and hapten-antibody enzymatic labeling (TSA). Prede-
fined amounts of 10 exogenous A. thaliana mRNAs were
added to two rat BT4C total-RNA samples (from two dif-
ferent treatments of cells), resulting in known ratio distri-
bution for the spikes (range: 0.125 – 6.0; See Methods).
The observed ratios of the 10 spikes (calculated as MMR =
median of medians of ratios) (Table 1) showed that spikes
with ratios below 1.0 were best reproduced with the TSA
method, whereas FairPlay showed the largest deviations
from the expected values for these spikes. For Spike 1,
only CyScribe showed an observed value close to the
expected 1.0. The other four methods produced higher
values than 1.0. The TSA method showed the largest devi-
ations from expected values for spikes with expected ratios
in the range 2.0 – 6.0 (Table 1). The between-array varia-
tion with TSA was also highest for these large ratio-spikes.
In summary, the overall relative deviations from the
expected ratios (Table 2) showed that CyScribe, 3DNA50
and 3DNA had the lowest values (16%, 17% and 24%
respectively), while both TSA and FairPlay showed the
largest relative deviations (48% and 36% respectively).
We calculated the median total coefficient of variation of
ratios (CV) over the 10 spikes in each method as seen in
Table 2. The FairPlay method showed the lowest total
experimental CV (22%) followed by 3DNA50 and
CyScribe (26% and 38% respectively). The TSA and 3DNA
methods showed the largest total experimental variations
(45%). The total variability was decomposed into varia-
bility between arrays and variability within array using a
one-way analysis of variance (see Methods). The between-
array variations were almost two times higher than the
within-array variations for all of the five methods, except
for the 3DNA method (Table 2).
A combined evaluation of accuracy and reproducibility
was studied using the parameter relative accuracy and
reproducibility (RAR; See Methods) (Table 2). 3DNA50
and CyScribe showed the lowest RAR (0.10 and 0.17
respectively), whereas methods using low amounts of
starting RNA (3DNA and especially TSA), showed high
RAR values (0.28 and 0.68 respectively).
Shrinkage of relative expression ratios in microarrays,
especially for the 3DNA method, has previously been
reported by several investigators [15,16]. We did not
observe shrinkage of the spike ratios for the 3DNA
method, although we detected saturation at the high end
of observed ratios for this method. Experiments giving a
Table 1: Expected and observed Cy5/Cy3 ratios for Arabidopsis spike controls in cDNA microarray hybridizations using five different 
labeling methods.
Spikes Expected ratio Observed ratio for the five methods1: Range3 of MMR values
12 3 4 5
CyScribe [50 µg]2 FairPlay [20 µg] TSA [5 µg] 3DNA [5 µg] 3DNA50 [20 µg]
Spike 7 0.125 0.16 (0.05)4 0.17 (0.05) 0.10 (0.04) 0.10 (0.06) 0.17 (0.04) 0.10 – 0.17
Spike 10 0.25 0.28 (0.09) 0.44 (0.11) 0.25 (0.11) 0.26 (0.17) 0.37 (0.10) 0.25 – 0.44
Spike 9 0.33 0.25 (0.08) 0.49 (0.18) 0.27 (0.11) 0.22 (0.13) 0.27 (0.10) 0.22 – 0.49
Spike 8 0.50 0.60 (0.21) 0.67 (0.11) 0.46 (0.14) 0.45 (0.17) 0.46 (0.11) 0.45 – 0.67
Spike 1 1.00 1.22 (0.41) 1.72 (0.28) 1.69 (0.69) 1.64 (0.83) 2.42 (0.65) 1.22 – 2.42
Spike 2 2.00 1.85 (0.70) 2.66 (0.64) 3.12 (1.20) 2.40 (0.51) 2.41 (0.53) 1.85 – 2.41
Spike 3 3.00 1.56 (0.60) 3.58 (1.36) 4.20 (1.90) 3.85 (0.70) 3.44 (0.79) 1.56 – 4.20
Spike 4 4.00 3.92 (1.34) 4.85 (0.95) 7.04 (2.77) 5.15 (1.26) 4.24 (1.06) 3.92 – 7.04
Spike 5 5.00 5.63 (1.80) 7.22 (1.39) 13.99 (6.56) 7.66 (1.25) 5.78 (1.45) 5.63 – 13.99
Spike 6 6.00 5.94 (2.04) 7.97 (1.90) 18.63 (10.64) 5.38 (1.13) 6.28 (1.16) 5.38 – 18.63
1The observed ratio values for the first four protocols are median of medians of ratios (MMR) from four replicate hybridizations. For the 3DNA50 
method, the data are based on three replicate hybridizations. 2µg total RNA used in labeling reactions. 3The range is given over MMR values for the 
five different methods. 4The between-array standard deviations, given in parenthesis, represent the standard deviation of the four (three) MMR 
values from the replicate hybridizations for each method.BMC Biotechnology 2003, 3 http://www.biomedcentral.com/1472-6750/3/23
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more accurate evaluation of shrinkage should presumably
include spikes with even larger expected ratios than pre-
sented here.
The relatively high CV values seen with the TSA method
could be a result of high and non-uniform background
fluorescence that was seen for all four replicate hybridiza-
tions produced with this method (data not shown). High
background levels with the TSA method were also
reported by Richter and co-workers [15]. The 3DNA
method produced arrays with the lowest signal intensities,
which may in turn explain the large experimental varia-
tion that was also observed with this method.
The RAR values calculated in this study could indicate a
positive correlation between RNA quantity in the labeling
reactions and the accuracy and reproducibility of the labe-
ling method. In the study conducted by Ritcher et al., both
direct and indirect methods were shown to be more relia-
ble than 3DNA and TSA methods when compared to
results with Nothern blots. Manduchi and colleagues [16]
reported similar observations regarding the overall per-
formance of the direct, indirect, and 3DNA methods.
Conclusions
In conclusion, the 3DNA50 and CyScribe methods
showed the best overall performance. The FairPlay
method had the lowest experimental variation, but
showed consistently higher values than the expected val-
ues. TSA had both the largest experimental variation and
the largest deviation from the expected values.
When the amount of starting RNA was not a limitation,
we showed that all of the three labeling methods,
3DNA50, CyScribe, or FairPlay, had comparable perform-
ances. Using small quantities of total RNA as template, the
3DNA method was the better of the two methods ana-
lyzed (i.e. 3DNA and TSA). However, as the 3DNA
method showed considerable experimental variation, we
therefore suggest that researchers also look into labeling
methods other than the two presented here when the
amount of input RNA is small. The use of amino C6dT-
modified random hexamers to prime cDNA synthesis in
conjunction with aminoallyl dUTP [17], or RNA amplifi-
cation methods [18,19] could be alternatives. The use of
resonance light scattering (RLS) particles in signal detec-
tion is another promising technology, which also allows
small amounts of starting RNA [20].
Methods
Rat cDNA microarrays
The rat cDNA microarrays used in this study, were printed
and purchased from The Norwegian Microarray Consor-
tium (NMC: http://www.mikromatrise.no/). In addition
to the ~13800 sequence verified rat cDNA probes from
Research Genetics (Huntsville, AL, USA; http://www.res
gen.com/) printed in duplicates on amino silane coated
slides (CMT GAPS II, Corning Life Sciences, Corning, NY),
ten different cDNAs from Arabidopsis thaliana (Spot-
Report™, Stratagene, La Jolla, CA, USA) were each printed
32 times on the slides.
Cell culturing and RNA isolation
Total RNA was extracted from BT4C rat glioma cells
treated with drug (1 mM LiCl) or saline (1 mM NaCl)
using the GenElute™ Mammalian Total RNA Miniprep Kit
(Sigma-Aldrich, St. Louis, MO, USA). One large batch of
total RNA from each treatment was quality-controlled
using UV-spectrophotometry and the BioAnalyzer 2100
(Agilent, Palo Alto, CA, USA) and then used for all micro-
array experiments.
cDNA labeling
Prior to reverse transcription, exactly defined amounts of
exogenous A. thaliana mRNAs (SpotReport™, Stratagene)
were added to the control RNA and to the test RNA, giving
expected ratios in the range 0.125 to 6.0 (Table 1) in a
microarray experiment.
Table 2: Accuracy and reproducibility of five different labeling methods in cDNA microarray hybridizations1.
cDNA labeling method Relative deviation from 
expected values
Total CV2 Ratio of variability between 
and within arrays3
RAR4
CyScribe 0.16 0.38 2.09 0.17
FairPlay 0.36 0.22 1.49 0.20
TSA 0.48 0.45 1.78 0.68
3DNA 0.24 0.45 0.88 0.28
3DNA50 0.17 0.26 1.43 0.10
1The table shows only the overall values calculated as the median of ten individual values belonging to the ten spikes. 2CV is the total coefficient of 
variation of the ratio data. 3The values given are the square root of ratio between the treatment sum of squares (between arrays) and the error 
sum of squares (within array) from a one-way analysis of variance (see Methods). 4RAR is the relative accuracy and reproducibility (see Methods).BMC Biotechnology 2003, 3 http://www.biomedcentral.com/1472-6750/3/23
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The following cDNA labeling kits were used (µg total RNA
is given in Table 1): 1) CyScribe First Strand cDNA Labeling
Kit (Amersham Biosciences, Little Chalfont, Buckingham-
shire, England), 2) FairPlay™ Microarray Labeling Kit (Strat-
agene), 3) MICROMAX™ TSA™ Labeling and Detection Kit
(Perkin Elmer Life Sciences, Boston, MA, USA), 4) 3DNA®
Submicro™ Expression Array Detection Kit (Genisphere Inc,
Hatfield, PA, USA) and 5)3DNA® Array 50™ Expression
Array Detection Kit (Genisphere Inc).
The amount of starting RNA used for the different meth-
ods was chosen based on the recommendations from the
manufacturers protocols and is shown in Table 1. All
cDNA labeling reactions were performed as recom-
mended by the manufacturers, but with the following
modification:
The labeled cDNA samples were purified and upconcen-
trated using Microcon® columns (YM-30; Millipore, Bed-
ford, MA, USA) in all protocols except for the 3DNA
Submicro Expression Array Detection Kit.
Hybridization
Identical prehybridizations were performed for all 20
microarray experiments. The arrays were incubated for 45
min in a 50 ml plastic tube containing 35 ml of prehybrid-
ization buffer (5x SSC, 0.1% SDS, 1% BSA) at 65°C, fol-
lowed by washing in ddH2O (five times each in two
separate tubes; RT), and in isopropanol (five times; RT),
and then dried by centrifugation at 1000 rpm for 2 min in
a microplate centrifuge.
For the CyScribe, FairPlay and TSA Micromax methods,
the hybridization-mixture was slightly modified com-
pared to manufacturer's recommended procedure: 7.9 µl
20x SSC, 1.4 µl 10% SDS, 2.5 µl 50x Denhardt, 1 µl yeast
tRNA (4 µg/µl), 1 µl poly d(A) (6 µg/µl) and 2 µl 1% BSA
were added to the labeled and purified cDNA. The final
volume was adjusted to 45 µl by adding 10 mM Tris (pH
8.0). This hybridization-mixture was denatured for 4 min
at 96°C, centrifuged for 5 min in a microcentrifuge and
then immediately applied to the prehybridized microar-
ray slide. The slide was incubated overnight (~16 hours)
at 65°C inside a hybridization chamber (ArrayIt™; Tel-
eChem International Inc., Sunnyvale, CA, USA) in a
waterbath. For both 3DNA methods, the 2-step hybridiza-
tion protocol provided by the manufacturer was used.
The post hybridization treatment and washing were per-
formed as recommended by the manufacturers for both
3DNA methods and the TSA method. The following wash-
ing was performed for the CyScribe and FairPlay methods:
The slides were washed in 2x SSC, 0.1% SDS (~65°C) to
remove the cover-slip, followed by three subsequent
washing steps with agitation: 1x SSC (~65°C; 5 min), 0.2x
SSC (RT; 5 min), 0.05x SSC (RT; 1 min), and finally spun
dry by centrifugation at 1000 rpm for 2 min in a micro-
plate centrifuge.
A total of four arrays were hybridized for each labeling
method. The same quality-controlled array batch was
used for all experiments and the same person did all of the
hybridizations.
Scanning and data analysis
All arrays were scanned with the GenePix® 4000B scanner
(Axon Instruments Inc., Union City, CA, USA), followed
by image analysis with the GenePix® Pro 3.0 image analy-
sis software (Axon Instruments). Median intensity of the
spot and local background was then derived and trans-
ferred to the R language and environment for statistical
computing and graphics http://www.r-project.org/. Filter-
ing was performed by first excluding spots automatically
flagged by the GenePix software. Then spots with back-
ground-subtracted intensities less than 200 in both chan-
nels were removed. Finally spots with signal-to-local
background ratios (S/B) less than 1.5 in any of the two
channels were excluded.
We normalized the log2-ratio data (spike values not
included) by using print-tip group loess normalization
(degree 2 and span 0.4) as described by Yang et al. [21].
The spike ratios were then adjusted by normalization fac-
tors obtained from the loess curves. This normalization
procedure was equally applied to all arrays.
Statistics
Median of medians of ratios (MMR). For each spike we cal-
culated the median of ratios within each array and then
calculated the median of these median ratios from the
replicate arrays, obtaining one total measure of expression
ratio for each spike.
Relative deviation from the expected values (RD) represents
the absolute difference between MMR and the
corresponding expected ratio expressed as a percentage of
the expected ratio.
Total coefficient of variation of ratios (CV) for each spike was
calculated as the ratio of standard deviation (over 128
ratios; 32 pr. array times four replicate arrays) to the
median instead of the mean.
Relative accuracy and reproducibility (RAR) was calculated as
the sum of the squared RD and the squared total CV for
each spike, representing a combined measure of accuracy
and reproducibility for that spike ratio.
A one-way analysis of variance (ANOVA) was fitted to the
log-ratio data for each spike in each method (32 observa-Publish with BioMed Central    and   every 
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tions for each of four arrays), with array as a "treatment
effect". The total variability for each spike was decom-
posed into variability between arrays (treatment sum of
squares), and variability within array (error sum of
squares). All statistical analyses were done using the R
language.
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